Authors:
COUTANT R
CAREL JC
LETRAIT M
BOUVATTIER C
CHATELAIN P
COSTE J
CHAUSSAIN JL
Citation: R. Coutant et al., SHORT STATURE ASSOCIATED WITH INTRAUTERINE GROWTH-RETARDATION - FINALHEIGHT OF UNTREATED AND GROWTH HORMONE-TREATED CHILDREN, The Journal of clinical endocrinology and metabolism, 83(4), 1998, pp. 1070-1074
Authors:
COSTE J
LETRAIT M
CAREL JC
TRESCA JP
CHATELAIN P
ROCHICCIOLI P
LOUIS J
CHAUSSAIN JL
JOB JC
Citation: J. Coste et al., LONG-TERM RESULTS OF GROWTH-HORMONE TREATMENT IN FRANCE IN CHILDREN OF SHORT STATURE - POPULATION, REGISTER-BASED STUDY, BMJ. British medical journal, 315(7110), 1997, pp. 708-713
Authors:
CAREL JC
TRESCA JP
LETRAIT M
CHAUSSAIN JL
LEBOUC Y
JOB JC
COSTE J
Citation: Jc. Carel et al., GROWTH-HORMONE TESTING FOR THE DIAGNOSIS OF GROWTH-HORMONE DEFICIENCYIN CHILDHOOD - A POPULATION REGISTER-BASED STUDY, The Journal of clinical endocrinology and metabolism, 82(7), 1997, pp. 2117-2121
Authors:
LETRAIT M
LURIE A
BEAN K
MESBAH M
VENOT A
STRAUCH G
GRANDORDY BM
CHWALOW J
Citation: M. Letrait et al., THE ASTHMA IMPACT RECORD (AIR) INDEX - A RATING-SCALE TO EVALUATE THEQUALITY-OF-LIFE OF ASTHMATIC-PATIENTS IN FRANCE, The European respiratory journal, 9(6), 1996, pp. 1167-1173
Authors:
STRAUCH G
PERLES P
TRESCA JP
LETRAIT M
BROUDIC I
DELCHAMBRE J
Citation: G. Strauch et al., MEDROGESTONE INHIBITS OVULATION WHEN GIVEN FROM DAY-4 TO DAY-24 OF THE CYCLE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 172-172
Authors:
STRAUCH G
PERLES P
TRESCA JP
LETRAIT M
BROUDIC I
DELCHAMBRE J
Citation: G. Strauch et al., MEDROGESTONE INHIBITS OVULATION WHEN GIVE N FROM DAY 4 TO 24 OF THE CYCLE, Contraception fertilite sexualite, 22(11), 1994, pp. 705-708
Authors:
LAROCHE F
KAHAN A
KAHAN A
LETRAIT M
COHEN C
JAMIN P
STRAUCH G
Citation: F. Laroche et al., KETOPROFEN AND PREDNISOLONE DO NOT MODULATE NEUTROPHIL CR-1, CR3 AND FC-GAMMA-RIII EXPRESSION IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 38(5), 1994, pp. 441-445
Citation: J. Coste et al., RELIABILITY OF HORMONAL LEVELS FOR ASSESSING THE HYPOTHALAMIC-PITUITARY-ADRENOCORTICAL SYSTEM IN CLINICAL-PHARMACOLOGY, British journal of clinical pharmacology, 38(5), 1994, pp. 474-479
Authors:
BERTAGNA X
COSTE J
RAUXDEMAY MC
LETRAIT M
STRAUCH G
Citation: X. Bertagna et al., THE COMBINED CORTICOTROPIN-RELEASING HORMONE LYSINE VASOPRESSIN TEST DISCLOSES A CORTICOTROPH PHENOTYPE, The Journal of clinical endocrinology and metabolism, 79(2), 1994, pp. 390-394
Authors:
LAROCHE F
KAHAN A
KAHAN A
LETRAIT M
COHEN C
JAMIN P
STRAUCH G
Citation: F. Laroche et al., MECHANISMS OF ACTION OF KETOPROFEN AND PREDNISOLONE - LACK OF EFFECT ON CR-1, CR3 AND FC-GAMMA-RIII EXPRESSION ON HUMAN NEUTROPHILS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 150-150
Authors:
COSTE J
STRAUCH G
LETRAIT M
PINQUIER JL
LUTON JP
BERTAGNA X
Citation: J. Coste et al., RELIABILITY OF HORMONAL LEVELS TO ASSESS THE PITUITARY-ADRENAL AXIS -IMPLICATIONS FOR STUDY DESIGN, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 186-186
Authors:
COPIE X
PINQUIER JL
LETRAIT M
PALTIAT MH
PELLO JY
REY E
CHANTECLAIR G
DELAUTURE D
OLIVE G
STRAUCH G
Citation: X. Copie et al., EFFECT OF DIMETICONE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ETHYL BISCOUMACETATE, Therapie, 48(2), 1993, pp. 119-123